Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions

Carcinogenesis
Binaifer R BalsaraJoseph R Testa

Abstract

AKT is frequently activated in various cancers, but its involvement in lung tumor development and progression is not well established. We examined AKT activity by immunohistochemistry in 110 non-small cell lung carcinomas (NSCLCs) using tissue microarrays. AKT activation was observed in 56 (51%) tumors. To further validate activation of the AKT pathway in this series, we examined the phosphorylation status of the mammalian target of rapamycin (mTOR) and forkhead (FKHR), two downstream targets of AKT. Positive staining for phospho-mTOR and phospho-FKHR were detected in 74% and 68% of tumors, respectively, and was significantly associated with activation of AKT. Tumors positive for phosphorylated (active) AKT were present with a similar frequency in low stage (I/II) and high stage (III/IV) tumors, raising the possibility that AKT activation occurs early in tumor progression. We therefore examined AKT activity in 25 bronchial epithelial lesions from 12 patients at high risk of lung cancer. Metaplastic/dysplastic areas showed AKT activity, whereas normal and hyperplastic bronchial epithelia exhibited little or no activity. Since some bronchial epithelial lesions may develop into invasive cancers, we examined the effect of AKT on in...Continue Reading

Citations

Nov 12, 2005·Journal of Cancer Research and Clinical Oncology·Megumi SenjuEisaburo Sueoka
Nov 15, 2006·Journal of Biomedical Science·Sun-Long ChengGregory Jiazer Tsay
Sep 4, 2012·Indian Journal of Surgical Oncology·R Vijayalakshmi, Arvind Krishnamurthy
Nov 19, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yuanzi YuMingzhou Guo
Aug 4, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Yoh DobashiAkishi Ooi
May 12, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ji Hun KimWoo Ho Kim
Oct 6, 2005·Nature Clinical Practice. Oncology·Michael B Sporn, Karen T Liby
Dec 13, 2005·Nature Reviews. Cancer·Andreas G BaderPeter K Vogt
Nov 17, 2005·Oncogene·Deborah A Altomare, Joseph R Testa
Nov 17, 2005·Oncogene·Jin Q ChengSanto V Nicosia
Jun 25, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-C SoriaV Papadimitrakopoulou
Sep 7, 2007·Pathology International·Koji OkudelaHaruhiko Sugimura
Dec 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Regan M Memmott, Phillip A Dennis
Sep 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwang Woon KimBo Lu
Mar 5, 2011·Cancer Prevention Research·Joel M ReidUNKNOWN Cancer Prevention Network
Jan 23, 2009·Journal of Hematology & Oncology·Jed A KatzelZujun Li
Apr 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen Wee MaManuel Hidalgo
Apr 12, 2014·PloS One·Nicolle M Linnerth-PetrikSarah K Wootton
May 15, 2013·Chinese Journal of Cancer·Wei ZhouPaula M Vertino
Jan 5, 2013·Biochimica Et Biophysica Acta·S E KorsseW van Veelen
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hong LiuMina J Bissell
Jan 31, 2012·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Hyun-Soo KimYoun Wha Kim
Aug 13, 2008·Expert Opinion on Therapeutic Targets·Linda S SteelmanJames A McCubrey
Sep 1, 2010·Expert Opinion on Medical Diagnostics·Kyoichi Kaira, Nobuyuki Yamamoto
Mar 29, 2014·Expert Opinion on Investigational Drugs·Morena FasanoFloriana Morgillo
Sep 24, 2015·Oncology Reports·Jagan M R PatlollaChinthalapally V Rao
Sep 13, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Vassiliki A PapadimitrakopoulouBruce E Johnson
Oct 26, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sinead Cuffe, Natasha B Leighl
May 17, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Simon EkmanFred R Hirsch
Jun 1, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Vassiliki Papadimitrakopoulou
Sep 9, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Johan VansteenkisteEckart Laack

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Respiratory and Critical Care Medicine
Pierre P MassionAdriana L Gonzalez
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Junji TsurutaniPhillip A Dennis
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Sug Hyung LeeNam Jin Yoo
© 2022 Meta ULC. All rights reserved